Biomeditsina va amaliyot jurnali, 2022 №1
Maqola mavzusi
MEDICAL TACTICS FOR CAVERNOUS SINUS THROMBOSIS IN PATIENTS WITH COVID-19 (217-226)
Mualliflar
ASHUROV Azimjon Mirzajonovich ASHUROV Olimjon Mirzajonovich MURATOV Nodir Nuriddinovich ORALOV Bekhruz Abdukarimovich
Muassasa
Republican institute of postgraduate medical education Tashkent city clinical emergency hospital Tashkent medical academy
Annotatsiya
A review of the literature shows that, based on the results of long-term observations, there are no scientific studies of the level of survival, quality of life of patients after enucleation with cavernous sinus thrombosis. We also see that there are almost no articles on the practice of ocular enucleation for SARS-CoV-2 cavernous sinus thrombosis in research databases such as PubMed, EMBASE Medline, ResearchIndex, Cochrane, Springer, Elsevier. Available articles are presented in the form of a small number of clinical observations and case histories. The progressive increase in the number of cases of cavernous sinus thrombosis in our country during the COVID-19 pandemic affected not only the type of surgical intervention in ophthalmology, but also its volume. This article deals with recommendations and contraindications for the practice of enucleation surgery and postoperative survival of patients.
Kalit so'zlar
coronavirus, cavernous sinus thrombosis, enucleation, evisceration.
Adabiyotlar
1. Рахматуллаева Г.К., Якубова М.М., Хамдамова Б.Б. в.б. СOVID-19 ассоциированный тромбоз кавернозного синуса. (клинический случай) // Журнал неврологии и нейрохирургических исследований. -2021. Специальный выпуск. -№1. –С. 214-217. 2. Coronavirus disease (COVID-2019) situation reports - Situation report 51. Coronavirus disease (COVID-2019) situation reports. online: World Health Organisation, 2019 3. Latalska M, Mackiewicz J. The implication of ocular manifestation of COVID-19 for medical staff and patients-systematic review. Annals of agricultural and environmental medicine // AAEM. -2020. –Vol. 27. –P. 165-170 4. Ling XC, Kang EY-C, Lin J-Y, et al. Ocular manifestation, comorbidities, and detection of severe acute respiratory syndrome-coronavirus 2 from conjunctiva in coronavirus disease 2019: A systematic review and meta-analysis // Taiwan. J Ophthalmol. -2020 Sep 16. –Vol. 10(3). – P. 153-166 5. Lu C-w, Liu X-f, Jia Z-f. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020;395:e39 6. Seah I., Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm 2020;28:391-395 7. Seah IYJ, Anderson DE, Kang AEZ, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology 2020;127:977. 8. Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection. J Med Virol. 2020 Jun;92(6):589-594 9. Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye 2020;34:2352-2353. 10. Meduri G.U., Kohler G., Headley S., Tolley E., Stentz F., Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest 1995;108:1303-1314 11. American Academy of Ophthmalogy. List of urgent and emergent ophthalmic procedures. Available at; 2020. https://www.aao.org/headline/list-of-urgent-emergent-ophthalmicprocedures;. Accessed June 3, 2020 12. Grasselli G., Pesenti A., Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA 2020;323:1545-1546 13. Helms J., Tacquard C., Severac F., et al. High risk of thrombosis in patients with severe SARSCoV- 2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun;46(6):1089- 1098 14. Llitjos J.F., Leclerc M., Chochois C., et al. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients. J Thromb Haemost. 2020 Jul;18(7):1743-1746 15. COVID Surg Collaborative. Global guidance for surgical care during the COVID-19 pandemic. Br J Surg 2020; https://doi.org/10.1002/bjs.11646 16. Morris M, Pierce A, Carlisle B, Vining B, Dobyns J. Pre-operative COVID-19 testing and decolonization. Am J Surg 2020; 220(3):558–560 17. Steward JE, Kitley WR, Schmidt CM, Sundaram CP. Urologic surgery and COVID-19: how the pandemic is changing the way we operate. J Endourol 2020;34(5):541–549 18. Hakim AA, Kellish AS, Atabek U, Spitz FR, Hong YK. Implications for the use of telehealth in surgical patients during the COVID-19 pandemic. Am J Surg 2020;220(1):48–49 19. Орипов О.И., Умаров Р.З. Способ ранней визуализации COVID-19 ассоциированного тромбоза кавернозного синуса // Современные технологии в офтальмологии. -2021. -№ 2. –С. 190-192. DOI: https://doi.org/10.25276/2312-4911-2021-2-190-192 20. Билалов Э.Н., Умаров Р.З., Орипов О.И., Способ ранней лучевой диагностики при Covid- 19 ассоциированном тромбозе кавернозного синуса // Методические рекомендации. - Ташкент. -2021. 18 с. 21. Kelvin Y.C., Teo A.I., Giovanni S., Chui M.G. COVID-19 related retinal micro-vasculopathy – a review of current evidence // American Journal of Ophthalmology. – 2021. –P. 12-31. https://doi.org/10.1016/j.ajo.2021.09.019 22. Kasimova M.S., Umarov R.Z., Khamraeva G.Kh. Diagnostics of patients with thromboembolic complications of the visual organ of rhinosinusogenic etiology at covid 19 // Uzbek medical journal. -Tashkent, 2021. –Vol. 2. –Issue 1. –P. 21-26. http://dx.doi.org/10.26739/2181-0664- 2021-1-4 23. Хайдарова Ф.А., Алиева А.В., Камалов Т.Т., Таленова В.А., Состояние после тромбоза кавернозного синуса, осложненного остеомиелитом верхней челюсти после перенесенной коронавирусной инфекции у пациента с сахарным диабетом 2 типа // Juvenis scientia. 2021. Том 7. № 3. С. 28-35. 24. Abouhashem S, Eldawoody H, Taha MM. Cerebral venous sinus thrombosis in patients with COVID-19 infection. Interdiscip Neurosurg. 2021;24:101091. DOI: 10.1016/j.inat.2021.101091